Cefuroxime-Associated Pancreatitis
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Prolonged Coagulopathy With Dabigatran Despite Multiple Doses of Idarucizumab: A Case of Incomplete Reversal
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Salvage Therapy of Pembrolizumab and Bevacizumab in a Case of Advanced Pulmonary Adenocarcinoma With Multiple Brain Metastases
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Tacrolimus-Induced Hyperosmolar Hyperglycemic Syndrome and the Role of Phenytoin in Tacrolimus Toxicity
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Tracheobronchial Dilation (Mounier–Kuhn-like Syndrome) Secondary to Fluoroquinolones
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Meta-Analysis of the Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Patients With Polycystic Ovary Syndrome
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Re: “Commentary” by Rothrock et al. “Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19”
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Editorial Source Type: research
Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3): e299–e318
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Editorial Source Type: research
Repurposing Drugs for Post–COVID-19 Fatigue Syndrome: Methylphenidate, Duloxetine, and Brexpiprazole
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Editorial Source Type: research
Local and Intra-articular Administration of Nonsteroidal Anti-inflammatory Drugs for Pain Management in Orthopedic Surgery
Conclusion:
There is convincing evidence that NSAIDs administered locally in and around the joint reduce postoperative pain scores and opioid consumption in patients undergoing total joint arthroplasty, yet further research is required regarding the risks of potential chondrotoxicity and the inhibition of bone and soft-tissue healing with locally administered NSAIDs. (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Therapeutic Advance Source Type: research
Apixaban: An Optimal Agent for the Treatment of Cancer-Associated Venous Thromboembolism?
Background:
Apixaban, a direct inhibitor of activated coagulation factor X (FXaI), is being frequently selected for treatment and prevention of venous thromboembolism (VTE). Several reports about possible use of oral FXaI in patients with cancer-associated VTE (CA-VTE) have been published recently.
Areas of Uncertainty:
The efficacy/safety profile of oral FXaI anticoagulation in patients with CA-VTE seems promising; however, several problems remain unanswered. The pharmacologic profile of apixaban could prefer this agent for the treatment of CA-VTE.
Data Sources:
Currently available medical literature was...
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Therapeutic Opinion Source Type: research
Optimization of Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea With Ultrasound Assessment of Tongue Movement
Conclusion:
We demonstrated that ultrasound assessment of HBE during HGNS programming is a useful tool to optimize therapy. (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Therapeutic Opinion Source Type: research
Sodium–Glucose Cotransporter Inhibitors Reduce Mortality and Morbidity in Patients With Heart Failure: Evidence From a Meta-Analysis of Randomized Trials
Conclusions:
Therefore, the available evidence supports the routine use of these drugs as standard-of-care, also given the highly favorable NNTs. (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - March 1, 2022 Category: Drugs & Pharmacology Tags: Meta-analysis Source Type: research
